GlassScriptPhysician profile
Nirupa C Cuttler
NPI 1790097194
$2,034.22
in general payments reported to CMS, 2019-2025
22 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $45.25 · 2021: $237 · 2022: $89.97 · 2023: $283 · 2024: $511 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,218 · Education: $4.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,218.37 |
| Education | $4.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $328.77 | 2023-2025 | Envista Mx60 Iol, Ic-8 Apthera Iol, Stellaris |
| Allergan, INC. | $247.33 | 2019-2022 | |
| Alcon Vision LLC | $216.16 | 2019-2025 | Precision7 |
| Sun Pharmaceutical Industries INC. | $199.73 | 2022-2023 | Cequa |
| Regeneron Healthcare Solutions, INC. | $173.44 | 2023-2025 | Eylea Hd, Eylea |
| Rxsight INC | $162.94 | 2024-2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Glaukos Corporation | $111.53 | 2019 | |
| Novartis Pharmaceuticals Corporation | $104.58 | 2019-2023 | |
| Sandoz INC. | $93.26 | 2024 | Cimerli |
| Oyster Point Pharma, INC. | $60.33 | 2024-2025 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $54.15 | 2024 | Xdemvy |
| New World Medical,INC. | $50.14 | 2021 | |
| Ivantis, INC | $45.00 | 2019 | |
| Coherus Oncology, INC. | $31.00 | 2024 | |
| Abbvie INC. | $29.81 | 2023-2024 | Lumigan, Alphagan P |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $21.83 | 2025 | |
| Johnson & Johnson Surgical Vision, INC. | $19.36 | 2019 | |
| Apellis Pharmaceuticals, INC. | $18.43 | 2023 | Syfovre |
| Eyevance Pharmaceuticals LLC | $17.93 | 2021 | |
| Ani Pharmaceuticals, INC. | $16.98 | 2025 | Iluvien |
| Ocular Therapeutix, INC. | $16.53 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirupa Cuttler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.